Status:
COMPLETED
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Post Menopausal Osteoporosis
Eligibility:
FEMALE
55-80 years
Phase:
PHASE4
Brief Summary
This 2 arm crossover study will evaluate patient reported preference for either once monthly Boniva (150mg p.o.) or once weekly risedronate (35mg p.o.). Patients with post-menopausal osteoporosis will...
Eligibility Criteria
Inclusion
- ambulatory women with post-menopausal osteoporosis;
- patients who are bisphosphonate-naive, or who have previously received oral daily or i.v. bisphosphonate therapy (fulfilling certain criteria detailed in the protocol).
Exclusion
- malignant disease diagnosed within previous 10 years (except for successfully resected basal cell cancer;) breast cancer within previous 20 years;
- inability to stand or sit upright for at least 60 minutes;
- disease/disorder/treatment with drugs known to influence bone metabolism.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT00377234
Start Date
May 1 2006
End Date
August 1 2008
Last Update
August 1 2016
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35294-3708
2
Mesa, Arizona, United States, 85213
3
Scottsdale, Arizona, United States, 85251
4
Jonesboro, Arkansas, United States, 72401